15 November 2012 - Regenerative medicine company SANUWAVE Health Inc (OTC BB:SNWV) stated on Wednesday ia net loss of USD1.447m (USD0.07 per share) for the three months ended 30 September 2012.

This reflects a reduction in the net loss of USD624,268, or 30%, when compared to the net loss of USD2.07m or (USD0.10 per share) for the same period in 2011.

Revenues for the three months ended 30 September 2012 were recorded as USD178,256, up 10% when compared to revenues of USD161,678 for the same period in 2011. The company attributed this to increased sales of refurbishment applicators for devices due to the increased number of devices in use in 2012 as compared to 2011.

Research and development (R&D) expenses for the three months ended 30 September 2012 were reported at USD440,193, a decline of 29% compared to R&D of USD623,318 for the same period in 2011, which was due to lower expenses for clinical results analysis and clinical related expenses as compared to same period in 2011.